Objective
Brief description:
Prion diseases (transmissible spongiform encephalopathies, TSE) are a group of rare fatal progressive neurological disorders including Creutzfeldt-Jakob disease (CJD) in humans as well as bovine spongiform encephalopathy (BSE) and scrapie in animals. Classical CJD has a world-wide incidence of one case per million per year. These diseases are unique in being both horizontally transmissible as well as sometimes hereditary diseases. The infectious agent has been termed prion. The only molecule consistently found in infectious preparations is the scrapie isoform of the prion protein (PrPsc). This protein derives from a normal cellular isoform of the prion protein (PrPC) which is encoded in the genome of all mammals investigated to date. As a prerequisite for the development of thereapeutic strategies a much better understanding of the spread of the infectious agent and its deleterious effects in infected individuals, i.e. the pathogenesis of prion diseases, is mandatory. Our collaboration addresses several crucial questions in the pathogenesis of prion diseases. It is focused on four aspects, in particular concerning the role of peripheral and central immune cells, the Iymphoreticular system and microglia:
The role of follicular dendritic cells and the Iymphoreticular system(LRS) in agent replication.
The involvement of the LRS particularly after oral infection.
Mechanisms of neuroinvasion after oral infection.
The activation or microglia and interaction of microglia with neurons leading to nerve cell death.
In this collaboration a number of highly complicated methodologies such as transgenic animal techniques, brain cell transplantation and microglial tissue culture will be joined to elucidate questions of cellular pathogenesis and spread of the infectious agent in the infected organism.
Keywords:
Prion diseases, transmissible spongiform encephalopathies, BSE, scrapie, Creutzfeldt-Jakob disease, lymphoreticular system, follicular dendritic cells, microglia, transgenic animals, cell culture
Prion diseases (transmissible spongiform encephalopathies, TSE) are a group of rare fatal progressive neurological disorders including Creutzfeldt-Jakob disease (CJD), Gerstmann-Strussler-Scheinker syndrome, fatal familial insomnia and kuru in humans as well as bovine spongi form encephalopathy (BSE) and scraple in animals. Classical CJD has a world-wide incidence of one case per million per year. These diseases are unique in being both horizontally transmissible as well as sometimes hereditary diseases (Prusiner, 1993). The infectious agent has been termed prion (Prusiner, 1982). This term here is used operationally independent of the exact biochemical nature of the agent. The only molecule consistently found in infectious preparations is the scrapie isoform of the prion protein (PrPsc). This protein derives from a normal cellular isoform of the prion protein (PrPC), which is encoded in the genome of all mammals investigated to date (Prusiner, 1991). PrPc is a glycoprotein of unknown function normally found in neurones (Kretzschmar et al. 1986) and glia (Moser et al. 1995). BSE has become a European scale problem.
The discovery of a new variant of CJD which most likely is caused by transmission of BSE to humans in 16 patients in the UK and France is cause for major concern. The number of people in the European Union possibly in the incubation period of the disease cannot at present be estimated. However, it is high time to devise new therapeutic strategies. As a prerequisite for this a much better understanding of the spread of the infectious agent and its deleterious effects in infected individuals, i.e. the pathogenesis of prion diseases, are mandatory. The projects presented here address several crucial questions in the pathogenesis of prion diseases.
Among these are:
1. The role of follicular dendritic cells and the lymphoreticular system(LRS) in agent replication;
2. The involvement of the LRS particularly after oral infection;
3. Mechanisms of neuroinvasion after oral infection;
4. The activation or microglia and interaction of microglia with neurons leading to nerve cell death. Thus several cellular mechanisms and interactions from peripheral infection to nerve cell damage are covered by the four partners in this application. This collaboration is focused on the cellular pathogenesis of prion diseases, in particular concerning the role of peripheral and central immune cells, the lymphoreticular system and microglia in an attempt to lay the foundation for future therapeutic strategies and does not touch on questions concerning the biochemical nature of the infectious agent which is being worked on by a great number of groups worldwide.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine psychiatry sleep disorders
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences basic medicine immunology
- medical and health sciences clinical medicine transplantation
- medical and health sciences basic medicine neurology
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
81377 MUENCHEN
Germany
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.